Lovastatin triggers ovarian tumor cells to undergo apoptosis by two mechanisms: first, by blocking HMGCR activity; and second, by increasing the level of doxorubicin within drug-resistant cells. The gene discussed is HMGCR; the disease is ovarian neoplasm.